ZTS · Healthcare
Zoetis Inc
49/100
Smart-money confidence2 of 3 sources positive
Moderate — mixed signals
company insiders are buying
Hedge funds
52
Congress
No data
Insiders
100
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Consensus buy — 2 of 3 sources positive →
Market cap
$31.1B
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Exchange
NYSE
About ZOETIS INC
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health…
Who's behind the signal
Every informed buyer we can see on ZTS, across all three feeds.
Hedge funds · 9
Markel Group (Tom Gayner)
New position
Millennium Management (Englander)
Increased +374%
Gotham Asset Mgmt (Greenblatt)
Increased +118%
Citadel Advisors
Increased +66%
Baillie Gifford & Co
Increased +8%
Polen Capital Management
Unchanged
+3 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
Company insiders
Buying
Recent buys3
Recent sells2
Congressional trades · 17 on record
Disclosures from 2015-01-14 to 2022-08-26
The newest disclosure we hold for this stock is 2022-08-26.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-08-26 | Alan S. Lowenthal · D-CA | House | Bought | $15,001 - $50,000 |
| 2022-06-28 | John R. Curtis · R-UT | House | Bought | $1,001 - $15,000 |
| 2022-01-06 | Kurt Schrader · D-OR | House | Sold | $1,001 - $15,000 |
| 2021-09-02 | Zoe Lofgren · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-08-09 | Zoe Lofgren · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2020-11-25 | Michael T. McCaul · R-TX | House | Bought | $15,001 - $50,000 |
| 2020-11-25 | Michael T. McCaul · R-TX | House | Sold | $15,001 - $50,000 |
| 2020-08-07 | Joe Courtney · D-CT | House | Sold | $1,001 - $15,000 |
| 2020-07-21 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
Show the other 7
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2020-03-27 | John R. Curtis · R-UT | House | Bought | $1,001 - $15,000 |
| 2020-03-23 | Zoe Lofgren · D-CA | House | Sold | $1,001 - $15,000 |
| 2019-12-31 | Joe Courtney · D-CT | House | Bought | $1,001 - $15,000 |
| 2019-12-18 | John B. Larson · D-CT | House | Sold | $15,001 - $50,000 |
| 2015-01-30 | David Perdue · R-GA | Senate | Sold | $15,001 - $50,000 |
| 2015-01-29 | David Perdue · R-GA | Senate | Sold | $1,001 - $15,000 |
| 2015-01-14 | David Perdue · R-GA | Senate | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
ZOETIS INC isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
1
New positions
4
Increasing
3
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.4×
% of portfolio
0.0%
Position change
NEW
0.0% of Markel Group's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+374%
0.1% of Millennium Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+118%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+66%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.4×
% of portfolio
0.0%
Position change
+8%
0.0% of Baillie Gifford & Co's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
—
0.1% of Polen Capital Management's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−72%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−24%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−94%
0.0% of D.E. Shaw & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ZOETIS INC
No insider trades found in the last 90 days
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ZOETIS INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime